Format

Send to

Choose Destination
BMJ. 2019 Jul 3;366:l4473. doi: 10.1136/bmj.l4468.

Should the supply of cannabis be legalised now?

Author information

1
House of Lords, London meachermc@parliament.uk robin.murray@kcl.ac.uk.
2
Imperial College London.
3
Reading.
4
Institute of Psychiatry, King's College, London.
5
London.
PMID:
31270061
DOI:
10.1136/bmj.l4468
[Indexed for MEDLINE]

Conflict of interest statement

Competing interests (Meacher et al): We have read and understood BMJ policy on declaration of interests and declare the following interests: MM is co-chair of the All Party Parliamentary Group for Drug Policy Reform. In this capacity MM has received grants from the Open Society Foundation for Drug Policy research and projects. OSF is a not-for-profit organisation. DN sits on the advisory boards of several research and pharmaceutical companies, which have no connection to medical cannabis. DN has been paid to speak by several pharmaceutical companies that do not produce medical cannabis products. DN founded and chairs the charity DrugScience, which is funded by individual donations, a grant from Open Society Foundations, book sales, and companies that produce cannabis. DN’s company Alcarelle seeks to develop less harmful recreational alternatives to alcohol. JL is employed as lead researcher by the not-for-profit Centre for Medicinal Cannabis and is cofounder and director of the not-for-profit Cannabis Patient Advocacy and Support Services. Both organisations exclusively focus on medicinal access for patients. Neither organisation is concerned with campaigning or lobbying for the legal regulation of cannabis for adult use. Competing interests (Murray et al): We have read and understood BMJ policy on declaration of interests and have the following interests to declare: RM has received honorariums for giving lectures for Janssen, Otsuka, Lundbeck, and Sunovian. He has attended one meeting of Canopy Growth Health regarding CBD. He is a member of the Cannabis-Based Medicinal Products Panel, advising the Advisory Committee for Drug Misuse and the Home Office.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center